Clinical Trials Sponsored by Hilary L Surratt, PhD
Total 1 results
-
Hilary L Surratt, PhDNational Institute on Drug Abuse (NIDA)Active, not recruitingHIV PreventionUnited States
Sponsors and Collaborators
- Eurotrials Brasil Consultores Cientificos Ltda
- Lilly PharmaceuticalCompany
- Iyad Naeem Muhammad, PhD
- Julian Taylor Green
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- Paulo Sérgio Gomes Nogueira Borges
- Korea Otsuka International Asia Arab
- Rivierduinen, Centre for Personality disorders Jelgersma
- Oblikue Consulting
- Cardiovascular Center Dedinje, Belgrade, Serbia
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- Plethora Solutions Ltd
- Foshan Sanshui District People's Hospital
- Sudimplant SAS - Groupe TBR
- S-Biotek Holding ApS
- United States Department of Defense (DOD)
- Arsha Vidya Tirtha
- Gunkang Pharmaceuticals, Inc
- University of Applied Sciences Jena
- View Full List
Medical Conditions
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Thyroid and Parathyroid Surgery
- Hypothermia Following Anesthesia, Sequela
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Blepharospasm of Both Eyelids
- Advance Directive Completion
- Brain Tumor, Primary
- Immunologically-induced Lung Disease
- Huntington Chorea
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Anemia Acute
- Visual Attention Span Deficit
- Serum Albumin Low
- Testicular Teratoma
- Gray Platelet Syndrome
- Chemotherapy-Induced Neutropenia
- Puberty, Delayed
- Malaria,Falciparum
- Deformity Flexion
- Vibration; Exposure
- View Full List
Drug Interventions
- F520
- MMV390048 120mg
- Bimatoprost 0.03% eye drops
- Cytisine
- Cyanoacrylate
- Acalabrutinib in combination with VR
- Sorafenib
- Pemetrexed
- Celecoxib
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- ABY-035 i.v.
- Standard medical therapy
- Ebselen
- Oxycodone
- Mineralocorticoid receptor antagonist
- Vosaroxin
- S-Adenosyl-Methionine
- Pegfilgrastim
- Furmonertinib 160 mg
- Rovalpituzumab tesirine
- View Full List
CROs by country
- Contract Research Organizations in Australia
- Contract Research Organizations in Austria
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Burkina Faso
- Contract Research Organizations in Greece
- Contract Research Organizations in Hungary
- Contract Research Organizations in Ireland
- Contract Research Organizations in Kazakhstan
- Contract Research Organizations in Kosovo
- Contract Research Organizations in Liberia
- Contract Research Organizations in Madagascar
- Contract Research Organizations in Poland
- Contract Research Organizations in Saint Lucia
- CRO list by country